Parkinsonisme

Klinisch beeld^1,2
Hoe vaak komt het voor? Wie zijn kwetsbaar?^3-5
Beloop^5,6
Wat kan het anders zijn?^7,8
Bijzonderheden^9-14
Preventie en behandeling^5,6,15-19

Mentzel CL, Bakker PR, van Os J, et al. Blink rate is associated with drug-induced parkinsonism in patients with severe mental illness, but does not meet requirements to serve as a clinical test: the Curacao extrapyramidal syndromes study XIII. J Negat Results Biomed 2017; 16(1): 15.
Shin HW, Chung Drug-induced parkinsonism. J Clin Neurol 2012; 8(1): 15-21.
de Germay S, Montastruc F, Carvajal A, Lapeyre-Mestre M, Montastruc JL. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database. Parkinsonism Relat Disord 2020; 70: 55-9.
Bakker PR, de Groot IW, van Os J, van Harten PN. Predicting the incidence of antipsychotic- induced movement disorders in long-stay patients: A prospective study. Epidemiology and psychiatric sciences 2013; 22(4): 375-9.
Factor SA, Lang AE, Weinberg AM. Drug induced movement disorders. Massachusetts: Blackwell Publishing; 2005.
Mentzel CL, Bakker PR, van Os J, et al. Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness: The Curacao Extrapyramidal Syndromes Study XII. J Clin Psychiatry 2017; 78(3): e279-e85.
Vandewalle W, Boon E, Sienaert P. [Movement disorders due to modern antidepressants and mood stabilizers]. Tijdschr Psychiatr 2015; 57(2): 132-7.
Zadikoff C, Munhoz RP, Asante AN, et al. Movement disorders in patients taking anticonvulsants. J Neurol Neurosurg Psychiatry 2007; 78(2): 147-51.
Jeong S, Cho H, Kim YJ, Ma HI, Jang S. Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson’s disease. PLoS One 2021; 16(3): e0247354.
Pieters LE, Bakker PR, van Harten PN. Asymmetric Drug-Induced Parkinsonism and Psychopathology: A Prospective Naturalistic Study in Long-Stay Psychiatric Patients. Frontiers in psychiatry 2018; 9: 18.
Nair P, Trisno R, Baghini MS, Pendharkar G, Chung H. Predicting Early Stage Drug Induced Parkinsonism using Unsupervised and Supervised Machine Learning. Annu Int Conf IEEE Eng Med Biol Soc 2020; 2020: 776-9.
Jang W, Han J, Park J, et al. Waveform analysis of tremor may help to differentiate Parkinson’s disease from drug-induced parkinsonism. Physiol Meas 2013; 34(3): N15-24.
Trisno R, Nair P, Martin D, et al. Using accelerometer as a diagnostic tool to detect drug- induced parkinsonism (DIP) secondary to first-generation anti-psychotic medications. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 2020; 28(3): 348-53.
Mentzel TQ, Lieverse R, Levens A, et al. Reliability and validity of an instrument for the assessment of bradykinesia. Psychiatry Res 2016; 238: 189-95.
Hong JY, Sunwoo MK, Oh JS, Kim JS, Sohn YH, Lee PH. Persistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter Imaging. PLoS One 2016; 11(6): e0157410.
Morley JF, Pawlowski SM, Kesari A, Maina I, Pantelyat A, Duda JE. Motor and non- motor features of Parkinson’s disease that predict persistent drug-induced Parkinsonism. Parkinsonism Relat Disord 2014; 20(7): 738-42.
Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013; 382(9896): 951-62.
Kashihara K, Maeda T, Yoshida K. Safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson’s disease-Results of a multicenter open trial. Neuropsychopharmacol Rep 2022; 42(2): 135-41.
Zhang H, Wang L, Fan Y, et al. Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis. Neuropsychiatr Dis Treat 2019; 15: 2137-49.